[e-drug] Access and barriers to essential drugs in Asia

e-drug
1

E-drug: Access and barriers to essential drugs in Asia
-------------------------------------------------------------------------

[Please reply directly to Joseph. Joseph, E-drug cannot handle attachments,
and please send messages in plain text, not html. E-druggers interested in
the abstract must approach Joseph directly. KM, moderator]

Dear E-drug listmembers,

I am undertaking reseach on the impact of patents on the ability of
governments in SAsian developing countries make available essential
medicines. I am unclear as to:
(i) which drugs are essential in Pakistan, Bangladesh, Nepal, Sri Lanka and
India;
(ii) the nature of the barriers: patents, prices, lack of infrastructure,
government's health policy, corruption.

Any assistance greatfully received. I enclose an abstract for your perusal.

Thanks in advance
Joseph Savirimuthu
Lecturer in Law
The Liverpool Law School
University of Liverpool
Chatham Street
Liverpool
L69 7ZS
email: jsaviri@liverpool.ac.uk
Tel: 0151 794 2806
Fax: 0151 794 2829

--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html